Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
MEI Pharma, Inc. (MEIP) had Return on Tangible Equity of -13.17% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.57M |
|
-- |
|
-- |
|
$2.77M |
|
$-2.77M |
|
$0.20M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.57M |
|
$-2.77M |
|
$-2.77M |
|
6.66M |
|
6.66M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$20.78M |
|
-- |
|
-- |
|
$20.78M |
|
$1.24M |
|
-- |
|
-- |
|
$1.24M |
|
$19.54M |
|
$19.54M |
|
$19.54M |
|
6.66M |
|
| Cash Flow Statement Financials | |
$-18.38M |
|
$35.15M |
|
-- |
|
$3.71M |
|
$20.47M |
|
$16.77M |
|
$-0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.17% |
|
|
Return on Tangible Equity |
-13.17% |
-12.38% |
|
-13.17% |
|
$2.93 |
|
$-2.76 |
|
$-2.76 |
|